BMRN $88.05 -2.73 (-3.01%)
Fri, Mar 22, 2019
BioMarin Pharmaceutical Inc is a Health Care stock that trades on the NASDAQ with a market cap of $16.19 Billion
BioMarin's focus is on rare-disease therapies. Genzyme (now part of Sanofi) markets Aldurazyme through its joint venture with BioMarin, and BioMarin markets Naglazyme, Vimizim, and Brineura independently. BioMarin also markets Kuvan and Palynziq to treat the rare metabolic disorder PKU (in addition to long-standing U.S. rights, BioMarin has reacquired international rights for Kuvan and Palynziq from Merck KGaA). BioMarin has a hemophilia A gene therapy and a treatment for achondroplasia in late-stage clinical trials. http://www.bmrn.com
BioMarin Pharmaceutical Inc Stock Charts
BMRN Stock Price
Below are a few key dates for the stock price.
Year To Date
The most recent stock price is $88.05.
The Year To Date (YTD) return is +3.64%.
52 Week Low
The 52 Week Low stock price is $76.01 set on Fri, Apr 6, 2018 which is 351 days ago.
The current price per share is 15.84% above the 52 week low.
52 Week High
The 52 Week High stock price is $106.07 set on Wed, Oct 17, 2018 which is 157 days ago.
The current price per share is -16.99% below the 52 week high.
All Time High
The All Time High stock price is $149.13 set on Mon, Jul 20, 2015 which is 1,342 days ago.
The current price per share is -40.96% below the all time high.
BMRN Stock Split History
BioMarin Pharmaceutical Inc has had 0 stock splits.
Below is the EPS, P/E Ratio and Earnings Date.
The EPS is -$0.02 and the P/E Ratio is 0.
A negative Earnings Per Share (EPS) means that this company is losing money and not profitable at this time.
Stocks can make big percentage moves on the earnings announcement.
Companies announce earnings either before the market open or after the close.
The Earnings Release Date for BioMarin Pharmaceutical Inc was Thu, Oct 25, 2018.
Since this earnings release 149 days ago, the stock price is down by -5.20%.
Many investors know the importance of a companies earnings report. Also, the market reaction to the earnings release can be even more important and can help in making a prediction of a future price forecast of the shares.
A significant post earnings announcement percentage move can continue or reverse an existing trend for several days or weeks after the earnings date.
The most recent Earnings Release Date was on Thu, Feb 21, 2019, which was 30 days ago.
Since this earnings date, the stock price is down by -2.88%.
BioMarin Pharmaceutical Inc Dividend
Below is important Dividend information.
BMRN currently does not pay a dividend.
You may like this list of best dividend stocks of 2019.
Below are some other Biotech & Pharma industry stocks like BioMarin Pharmaceutical Inc.